Editor’s Take: Meissner continues to strengthen its relationship with the state of Georgia by expanding and hiring locally.
Meissner Corporation held a ribbon-cutting for an X-ray irradiation services facility and groundbreaking for Phase 2 of a manufacturing campus. Both sites are situated in Athens-Clarke County, Ga.
The Athens campus was first announced as a $250 million investment in April 2023.
Why Georgia
The Phase 2 groundbreaking adds manufacturing space to the Athens campus, strengthening Meissner’s capabilities on the United States East Coast. It will complement Meissner’s headquarters manufacturing campus in Camarillo, Calif., and another facility in Castlebar, Ireland.
Meanwhile, adding X-ray services provides additional capacity for irradiation that Meissner says is “critical.” The added capacity applies to Meissner products as well as those of other clients. By committing to this, Meissner will be able to expedite shipment of irradiated, process-ready customer solutions.
Federal funds from the U.S. Department of Health and Human Services, and others, helped fund the additional X-ray irradiation capabilities.
“Our customers are asking for more sterilization capacity and more resilient supply chains,” CEO Christopher Meissner said. “Athens is how we deliver both impactfully. Adding X-ray irradiation and building out Phase 2 gives us the capability and the capacity to support life sciences customers … We are grateful to our partners in Athens-Clarke County and the State of Georgia, and to the people of Meissner.”
Other Meissner Happenings
Earlier this week, Meissner launched its single-use Automated Aliquoting System. This compact, recipe-driven automated process skid platform standardizes filling and transfer of bulk cell culture media, buffers, and other solutions.
Meissner continues to hire for quality, scientific, engineering, and IT roles. The company works with the University of Georgia, Georgia Institute of Technology, Athens Technical College, and others on collaborative opportunities.